Journal of Hematology, ISSN 1927-1212 print, 1927-1220 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Hematol and Elmer Press Inc
Journal website http://www.thejh.org

Case Report

Volume 4, Number 4, December 2015, pages 231-234

Rare Respiratory and Neurologic Adverse Reactions to Azacitidine in the Treatment of Myelodysplastic Syndrome of Patients Treated at the Ottawa Hospital

Figures

Figure 1.
Figure 1. CT of the chest after receiving seven cycles of azacitidine. Initial CT scan of the chest demonstrates bilateral ground-glass opacities with reticulation and patchy peripheral airspace consolidation. Findings had a predominant mid- and upper lobe distribution.
Figure 2.
Figure 2. CT of the chest 2 months after discontinuing azacitidine. CT scan of the chest 3 months after previous chest CT demonstrates significant progression of ground-glass opacities and reticulation with new and more widespread areas of consolidation. Findings were again more severe in the mid- and upper lobes.